Advertisement

Effects of Oral Cimetidine on Parathyroid Hormone and Calcitonin Plasma Levels in Uremic Patients

  • J. L. Sebert
  • P. H. Decourcelles
  • Ph. Moriniere
  • J. F. de Fremont
  • J. Gueris
  • R. Makdassi
  • J. Khassouf
  • M. Andrejak
  • A. Fournier
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 151)

Abstract

Reports concerning the effects of Cimetidine on parathyroid hormone levels in primary hyperparathyroidism (1–4) and in secondary hyperparathyroidism of renal failure (5–8) are increasing in number, but lead to disagreeing conclusions. These discrepancies are unclear and could be possibly explained by: 1) a variable compliance to treatment, since no measurement of plasma levels of Cimetidine has been made in these reports, 2) differences in specificity of parathyroid hormone immunoassays, since, in a studied group of hemodialysed patients, the lowering effect of Cimetidine on parathyroid hormone levels previously observed using a carboxyterminal antiserum (5), was not confirmed when the same samples were assayed a second time using an aminoterminal antiserum (9). It has also been suggested (8) that Cimetidine could act on the metabolic fate of circulating parathyroid hormone rather than on its secretion, thus explaining differences between results derived from either carboxy or aminoterminal immunoassays.

Keywords

Parathyroid Hormone Primary Hyperparathyroidism Uremic Patient Renal Osteodystrophy Parathyroid Hormone Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.C. Sherwood, F.W. Ackroyd, M. Garcia. Effect of Cimetidine on circulating parathyroid hormone in primary hyperparathyroidism. Lancet i: 616 (1980).CrossRefGoogle Scholar
  2. 2.
    F.J. Palmer, T.M. Sawyers, S.J. Wierzbinski. Cimetidine and hyperparathyroidism. Lancet i: 692 (1980).Google Scholar
  3. 3.
    S. Ljunghall, G. Akerstrom, C. Rubberg, L. Wide, H. Johansson. Cimetidine in primary hyperparathyroidism. Lancet ii: 480 (1980).CrossRefGoogle Scholar
  4. 4.
    M.F. Robinson, A.B. Hayles, H. III. Heath. Failure of Cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (Multiple endocrine neoplasia, Type I). J. Clin. Endocrinol, Metab. 51: 912 (1980).CrossRefGoogle Scholar
  5. 5.
    A.I. Jacob, D.Jr. Lanier, J. Canterbury, J.J. Bourgoignie. Reduction by Cimetidine of serum parathyroid hormone levels in uremic patients. N. Engl. J. Med. 302: 671 (1980).Google Scholar
  6. 6.
    C.J. Beehler, J.R. Beckner, C. Rosenquist, S.W. Shankel. Parathyroid hormone suppression by Cimetidine in the uremic patients. Ann. Inter. Med. 93: 840 (1980).Google Scholar
  7. 7.
    J.L. Vanherweghem, N. Bourgeois, M. Fuss. Cimetidine and parathyroid hormone levels. N. Engl. J. Med. 303: 395 (1980).PubMedGoogle Scholar
  8. 8.
    C.E. Fiore, L.S. Malatino, J.A. Kanis. Effects of Cimetidine on parathyroid hormone metabolism. Lancet i: 501 (1981).CrossRefGoogle Scholar
  9. 9.
    A.I. Jacob, J.F. Bourgoignies. Cimetidine and parathyroid hormone levels. N. Engl. J. Med. 303: 396 (1980).CrossRefGoogle Scholar
  10. 10.
    J.A. Kanis, M. Earnshaw, G. Heynen, J.G.G. Ledingham, D.O. Oliver, G.G. Russell, C.G. Woods, P. Franchimont, S. Gaspar. Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin. N. Engl. J. Med. 296: 1073 (1977).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Gueris, C. Ferriere. Hétérogénéité de la parathormone plasmatique chez l’homme. Pathol. Biol. 23: 821 (1975).PubMedGoogle Scholar
  12. 12.
    C. Desplan, A. Jullienne, M.S. Moukhtar, G. Milhaud. Sensitive assay for biologically active fragment of human parathyroid hormone. Lancet ii: 198 (1977).CrossRefGoogle Scholar
  13. 13.
    J.L. Sebert, A. Fournier, J. Gueris, G. Lambrey, J.F. de Fremont, P. Marie, R. Makdassi, A. Smadja, A. Marie, D. Kuntz, A. Ryckewaert, J. Quichaud, P.J. Meunier. Limit by hyperphosphatemia of the usefulness of vitamin D metabolites (1 — hydroxycholecalciferol and 25 hydroxycholecalciferol) in the treatment of renal osteodystrophy. Metab. Bone. Dis. and Rel. Res. 2: 217 (1980).CrossRefGoogle Scholar
  14. 14.
    P.L. Vigo, E.E. Polli, G. Milhaud, M.S. Moukhtar, C. Desplan, J. Duriez. Aminoterminal parathyroid hormone radioimmunoassay to evaluate bone status in renal failure. Lancet i: 443 (1981).Google Scholar
  15. 15.
    M.S. Moukhtar, A. Jullienne, P. Rivaille, G. Milhaud. Dosage radioimmunologique de la calcitonine humaine. Etude immunochimique et comparaison avec le dosage biologique. In: Radioimmunoassay and related procedures in clinical medicine and research p. 381, International Atomic Energy Agency, Vienna (1973).Google Scholar
  16. 16.
    A.M. Parfitt. Correction of plasma calcium measurements. Br. Med. J. 1: 520 (1974).PubMedCrossRefGoogle Scholar
  17. 17.
    W.C. Randolph, V.L. Osborne, S.S. Walkenstein, A.P. Intoccia. High-pressure liquid chromatographic analysis of Cimetidine, a histamine H2 — receptor antagonist in blood and urine. J. Pharm. Sci: 66: 1148 (1977).PubMedCrossRefGoogle Scholar
  18. 18.
    R. Larsson, G. Bodemar, B. Norlander. Oral absorption of Cimetidine and its clearance in patients with renal failure. Eur. J. Clin. Pharmacol. 15: 153 (1979).PubMedCrossRefGoogle Scholar
  19. 19.
    J.J. Schentag, F.B. Cerra, G. Calleri, E. Deglopper, J.Q. Rose, H. Bernhard. Pharmacokinetic and clinical studies in patients with Cimetidine associated mental confusion. Lancet i: 177 (1979).CrossRefGoogle Scholar
  20. 20.
    C.C. Doherty, F.A. O’Connor, M.G. Mc Geown. Cimetidine for duodenal ulceration in patients undergoing hemodialysis. Br. Med. J. 2: 1506 (1977).PubMedCrossRefGoogle Scholar
  21. 21.
    R.S. Longley, G.K. Hargis, E.N. Bowser, S.C. Kukreja, P.A. Johnson, B.L. Jackson, W.J. Kawahara, G.A. Williams. Parathyroid hormone and calcitonin secretion: role of histamine H2 receptors. Clin. Res. 28: 398 A (1980).Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • J. L. Sebert
    • 1
  • P. H. Decourcelles
    • 1
  • Ph. Moriniere
    • 1
  • J. F. de Fremont
    • 1
  • J. Gueris
    • 2
  • R. Makdassi
    • 1
  • J. Khassouf
    • 1
  • M. Andrejak
    • 1
  • A. Fournier
    • 1
  1. 1.Centre Hospitalier et UniversitaireAmiensFrance
  2. 2.Laboratoire de RadioimmunologieHôpital LariboisiereParisFrance

Personalised recommendations